Objective: To assess enoxaparin as bridging anticoagulant treatment in cardiac surgery. Methods: Prospective registry of those patients who underwent cardiac surgery in our centre between December ...

Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old, 74-kg ...

The researchers also found that the drug enoxaparin, a commonly used blood thinner, can block the viral protein from sticking to healthy cells. It does this by taking over the spots the protein ...

Most enoxaparin regimens were decreased to a fixed dose of 40 mg subcutaneously once daily. The average peak anti-factor Xa level was 0.25 IU/mL (range 0.08–0.59).

SAN FRANCISCO, Calif. — June 13, 2025 — Vial, a clinical-stage biotechnology company, announced that it has initiated the Phase 1 trial for a novel, subcutaneous, half-life extended monoclonal ...

Citation: Lin S, Zhang J, Dang X and Zhan Q (2025) Correction: Association of early enoxaparin prophylactic anticoagulation with ICU mortality in critically ill patients with chronic obstructive ...

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

Lilly to offer all doses of Zepbound vials at $499 or less per month. Company News. Published 06/16/2025, 06:53 AM. Lilly to offer all doses of Zepbound vials at $499 or less per month.

LOS ANGELES -- Drama, revelations, and TikTok royalty are coming together in an explosive reunion special. Hulu has released a sneak peek at "The Secret Lives of Mormon Wives: Reunion Special ...

Previously, Steqeyma was only approved as a 45mg/0.5mL and a 90mg/mL single-dose prefilled syringe for subcutaneous injection and a 130mg/26mL single-dose vial for intravenous infusion.